Clinical trial

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

NCT06586866

Study summary

ClinicalTrials.gov

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention JK-1201I Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-09-26

PhasePHASE2

Conditions

Triple Negative Breast Cancer (TNBC)unresolved

Brain Metastasasesunresolved

Interventions

JK-1201IDRUG

Sponsors & collaborators

JenKem Technology Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06586866 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.